Regnante Keith Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$7.85M

Insider Activity of Regnante Keith

According to the SEC Form 4 filings, Regnante Keith, being in a position of

  1. CHIEF FINANCIAL OFFICER at Keros Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 4739 shares for $77,483,
    over all time since 2023-06-08, has bought 0 shares, and sold 124739 shares for $5.56M.

Biography of Regnante Keith

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $77,4831100

Comparison of Insiders on Amount of Buys and Sells

2026-02-18SaleKeros Therapeutics, Inc.
KROS
CHIEF FINANCIAL OFFICER
4,739
0.0118%
$16.35$77,483-30.92%
2024-01-04SaleKeros Therapeutics, Inc.
KROS
CHIEF FINANCIAL OFFICER
40,000
0.1235%
$45.29$1.81M+13.26%
2023-11-04SaleKeros Therapeutics, Inc.
KROS
Chief Financial Officer
40,000
0.1912%
$45.29$1.81M+65.7%
2023-06-09SaleKeros Therapeutics, Inc.
KROS
Chief Financial Officer
20,000
0.073%
$45.42$908,367-6.54%
2023-06-08SaleKeros Therapeutics, Inc.
KROS
Chief Financial Officer
20,000
0.0688%
$47.79$955,872-16.16%
2019-02-19SaleWave Life Sciences Ltd.
WVE
Chief Financial Officer
2,596
0.0078%
$36.84$95,636-34.15%
2018-09-24SaleWave Life Sciences Ltd.
WVE
Chief Financial Officer
59,000
0.1383%
$37.95$2.24M-34.09%
2018-02-16SaleWave Life Sciences Ltd.
WVE
Chief Financial Officer
632
0.0021%
$51.85$32,769-20.8%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.